Pharmaceuticals

bluebird bio, now associated with restructuring and renamed Genetix Biotherapeutics in some sector commentary, remains one of the historically important companies in ex vivo gene therapy. The company developed approved therapies for beta-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.

BioVectra is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

BioNTech is one of the most important mRNA and immunotherapy biotechnology firms globally. The company became widely known through its COVID-19 vaccine partnership with Pfizer, but its original scientific identity is rooted in individualized cancer immunotherapy, mRNA platforms, and oncology innovation.

BioMarin Pharmaceutical is one of the most established rare disease developers globally. The company has built its institutional identity around genetic and metabolic disorders, enzyme replacement therapies, skeletal dysplasia, hemophilia gene therapy, and serious pediatric rare diseases.

Biogen remains one of the most historically important biotechnology firms, particularly in neuroscience. The company has long been associated with multiple sclerosis, neurodegenerative disease, rare neurological disorders, and advanced biologic medicines.

Bharat Biotech is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

BeiGene is one of the most important China-origin biotechnology companies and a major global oncology player. The company has built a broad cancer-focused portfolio and global clinical development infrastructure spanning hematologic malignancies, solid tumors, immuno-oncology, and targeted therapies.

Beam Therapeutics is one of the leading companies in base editing, a next-generation gene editing approach designed to make precise single-base changes without creating double-strand DNA breaks. This technology gives Beam a differentiated position within genetic medicine.

Bayer Pharmaceuticals remains a major global pharmaceutical business within Bayer AG, with strengths in cardiovascular medicine, ophthalmology, women’s health, oncology, hematology, and specialty care. Although Bayer as a group has faced significant pressures from its agricultural business and debt profile, its pharmaceutical division remains a relevant global platform.

Bavarian Nordic is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

Axsome Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 2 ranking categories Overview

Avid Bioservices is a biologics CDMO focused on mammalian cell culture, process development, clinical manufacturing, commercial manufacturing, and related analytical services. The company serves biotechnology and pharmaceutical sponsors developing monoclonal antibodies, recombinant proteins, enzymes, and other biologic products.

Avance Clinical is an Australian CRO focused on supporting biotechnology companies through early-phase and later-stage clinical development programs. The company is especially relevant for sponsors seeking to use Australia’s clinical trial environment, regulatory pathways, and investigator networks.

Autolus Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier II Cell & Gene Therapy Developers 1 ranking category Overview

AstraZeneca Rare Disease, built around Alexion, remains one of the leading rare disease platforms globally. The business is especially associated with complement biology and severe rare disorders affecting hematology, nephrology, neurology, and metabolic disease.

Astellas Pharma is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Global Pharmaceutical Companies 1 ranking category Overview

Ascendis Pharma is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 1 ranking category Overview

Arrowhead Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 1 ranking category Overview

argenx has become one of the most important rare disease and specialty immunology developers globally. Its platform is focused on antibody-based medicines for severe autoimmune diseases, including rare neuromuscular and immune-mediated conditions requiring specialist care.

Ardena is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview